PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
05-May-2026 Dental Floss Market: Driving Growth & Future Opportunities at 6% CAGR (2026-2030) Medi-Tech Insights
05-May-2026 Multi Cancer Early Detection Market In-depth Insights, Business Opportunities and Top Companies Analysis Forecast by 2030 Medi-Tech Insights
05-May-2026 AI Maverick Intel Highlights Accelerating Commercial Traction at HEAL Access as It Advances Proposed Acquisition ACCESS Newswire
05-May-2026 CBD Life Sciences Inc. (CBDL) Announces Launch of CBD Pouches Nicotine Free ACCESS Newswire
05-May-2026 Longwood Healthcare Leaders to Host MIT CEO, Off-the-Record Networking and Discussion Forum, Convening Life Science Thought Leaders at MIT Koch Institute ACCESS Newswire
05-May-2026 Europe Rejects Hemp, Marijuana CBD Safety - As U.S. Court Weighs Halting Medicare CMS Program Exposing Seniors To Unproven Products ACCESS Newswire
05-May-2026 Benign Prostatic Hyperplasia (BPH) Surgical Treatment Market 2026 Analysis & Forecast To 2031 By Key Players, Share, Trend, Segmentation, Top Leaders and Regional Medi-Tech Insights
05-May-2026 Immune Repertoire Sequencing Market: Global Market Growth Study, Future Trends, Demands, and Top Players Data by Forecast to 2031 Medi-Tech Insights
05-May-2026 Samenvatting: Kubota Vision Inc. sluit een leverings- en licentieovereenkomst met Laboratoires KÔL voor een kandidaat-geneesmiddel tegen de ziekte van Stargardt in het kader van de schrijnende gevallenregeling Businesswire
05-May-2026 Riassunto: Kubota Vision Inc. firma un accordo di fornitura e licenza con Laboratoires KÔL per un farmaco ad uso compassionevole candidato al trattamento della malattia di Stargardt Businesswire
05-May-2026 Kubota Vision Inc. unterzeichnet Liefer- und Lizenzvereinbarung mit Laboratoires KÔL über einen Wirkstoffkandidaten zur Behandlung der Stargardt-Krankheit im Rahmen einer Compassionate-Use-Behandlung Businesswire
05-May-2026 Resumen: Kubota Vision Inc. firma un acuerdo de suministro y licencia con Laboratoires KÔL para un fármaco candidato para el tratamiento de la enfermedad de Stargardt dentro del programa de uso compasivo Businesswire
05-May-2026 Faron Pharmaceuticals Ltd: Holding(S) In Company ACCESS Newswire
05-May-2026 AlzeCure Publishes its Interim Report for January – March 2026 ACCESS Newswire
05-May-2026 Egetis Announces Grant of Patent for MCT8 Deficiency Composition in The U.S. ACCESS Newswire
05-May-2026 Alligator Bioscience AB Reports Financial Results for The Period 1 January – 31 March 2026 and Provides a Business Update ACCESS Newswire
05-May-2026 Faron Pharmaceuticals Ltd: Directorate Appointment ACCESS Newswire
05-May-2026 Stevanato Group to Participate in Three Upcoming Investor Conferences Businesswire
05-May-2026 TriSalus Life Sciences Announces Launch of PREDICTT Clinical Trial Evaluating Pressure-Enabled Drug Delivery in Liver Tumors Businesswire
04-May-2026 UFP Technologies Announces Strong Q1 Results Businesswire